Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Reva Medical, Inc. (RVA)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Reva Medical, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1496268.
Total stock buying since 2014: $1,090,590.
Total stock sales since 2014: $579,624.
Total stock option exercises since 2014: $9,724,986.
Table 3. Detailed insider trading at Reva Medical, Inc. (RVA)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2019-11-11 | Stockman Robert Bernard (Director) | Buy | 372,218 | .00 | 0 |
| 2019-11-11 | Dovey Brian H (Director) | Sale | 3,722,188 | .00 | 0 |
| 2019-04-01 | Goldman Sachs International | Sale | 2,444,695 | .00 | 0 |
| 2018-06-29 | Kimes Richard M. (Senior VP, Operations) | Buy | 3,271 | 1.53 | 5,004 |
| 2018-06-29 | Groves Regina E (Chief Executive Officer) | Buy | 9,815 | 1.53 | 15,016 |
| 2018-06-29 | Roberts Brandi (SVP & Chief Financial Officer) | Buy | 4,907 | 1.53 | 7,507 |
| 2018-06-29 | Stockman Robert Bernard (Director) | Buy | 32,719 | 1.53 | 50,060 |
| 2018-06-29 | Thomas Robert Bain (Director) | Buy | 16,359 | 1.53 | 25,029 |
| 2018-06-29 | Oesterle Stephen N. (Director) | Buy | 16,359 | 1.53 | 25,029 |
| 2018-06-29 | Larkin C Raymond Jr (Director) | Buy | 19,631 | 1.53 | 30,035 |
| 2018-06-14 | Thomas Robert Bain (Director) | Buy | 2,500 | 1.74 | 4,350 |
| 2018-06-13 | Thomas Robert Bain (Director) | Buy | 2,500 | 1.86 | 4,650 |
| 2018-05-31 | Thomas Robert Bain (Director) | Buy | 3,000 | 2.08 | 6,240 |
| 2018-05-30 | Thomas Robert Bain (Director) | Buy | 2,000 | 2.06 | 4,120 |
| 2018-03-28 | Thomas Robert Bain (Director) | Buy | 5,000 | 2.99 | 14,945 |
| 2018-03-27 | Thomas Robert Bain (Director) | Buy | 5,000 | 3.02 | 15,089 |
| 2017-12-29 | Stockman Robert Bernard (Director) | Buy | 10,300 | 5.13 | 52,818 |
| 2017-08-29 | Groves Regina E (Chief Executive Officer) | Buy | 386 | 6.37 | 2,458 |
| 2017-08-23 | Groves Regina E (Chief Executive Officer) | Buy | 407 | 6.37 | 2,592 |
| 2017-08-21 | Groves Regina E (Chief Executive Officer) | Buy | 402 | 5.86 | 2,357 |
| 2017-08-17 | Kimes Richard M. (Senior VP, Operations) | Buy | 880 | 5.61 | 4,935 |
| 2017-08-17 | Groves Regina E (Chief Executive Officer) | Buy | 303 | 5.57 | 1,687 |
| 2017-05-17 | Schultz Robert K. (President & COO) | Sale | 55,000 | 6.66 | 366,300 |
| 2016-07-21 | Breckenridge Ross (Director) | Buy | 1,773 | 7.34 | 13,008 |
| 2016-07-21 | Nye Gordon E (Director) | Buy | 3,354 | 7.34 | 24,608 |
| 2016-07-15 | Groves Regina E (Chief Executive Officer) | Buy | 2,683 | 7.45 | 19,996 |
| 2016-07-15 | Keating Anne (Director) | Buy | 15,306 | 7.47 | 114,397 |
| 2016-07-15 | Thomas Robert Bain (Director) | Buy | 30,000 | 7.47 | 224,220 |
| 2016-07-14 | Stockman Robert Bernard (Director) | Buy | 20,126 | 7.45 | 149,999 |
| 2016-06-28 | Brandom Donald K. (SVP, Product Development) | Sale | 994 | 7.33 | 7,282 |
| 2016-06-24 | Brandom Donald K. (SVP, Product Development) | Sale | 3,079 | 7.36 | 22,673 |
| 2016-06-23 | Brandom Donald K. (SVP, Product Development) | Sale | 926 | 7.79 | 7,218 |
| 2016-06-17 | Brandom Donald K. (SVP, Product Development) | Sale | 5,000 | 7.76 | 38,810 |
| 2016-06-17 | Thomas Robert Bain (Director) | Buy | 2,500 | 7.79 | 19,465 |
| 2016-03-31 | Thomas Robert Bain (Director) | Buy | 2,500 | 8.42 | 21,057 |
| 2016-03-30 | Groves Regina E (Chief Executive Officer) | Buy | 925 | 8.60 | 7,956 |
| 2016-03-29 | Kimes Richard M. (Senior VP, Operations) | Buy | 500 | 8.39 | 4,197 |
| 2016-03-29 | Stockman Robert Bernard (Director) | Buy | 6,500 | 8.49 | 55,204 |
| 2015-12-04 | Anderson Jeffrey A. (SVP, Clinical & Regulatory) | Sale | 4,500 | 6.00 | 26,986 |
| 2015-11-17 | Brandom Donald K. (SVP, Product Development) | Sale | 5,000 | 5.59 | 27,970 |
| 2015-10-02 | Taylor Nicholas (10% Owner) | Option Ex | 4,375,000 | 2.17 | 9,493,750 |
| 2015-09-21 | Brandom Donald K. (SVP, Product Development) | Sale | 6,162 | 4.41 | 27,168 |
| 2015-09-18 | Brandom Donald K. (SVP, Product Development) | Sale | 200 | 4.28 | 855 |
| 2015-09-10 | Brandom Donald K. (SVP, Product Development) | Sale | 1,137 | 4.66 | 5,301 |
| 2015-09-03 | Brandom Donald K. (SVP, Product Development) | Sale | 2,500 | 5.12 | 12,790 |
| 2015-07-07 | Schultz Robert K. (President & COO) | Option Ex | 80,000 | 1.25 | 100,000 |
| 2015-07-01 | Zeltinger Joan K. (VP, Scientific Affairs) | Option Ex | 10,000 | 1.25 | 12,500 |
| 2015-06-04 | Breckenridge Ross (Director) | Buy | 1,000 | 4.09 | 4,090 |
| 2015-06-03 | Stockman Robert Bernard (Chairman and CEO) | Buy | 6,250 | 4.00 | 25,000 |
| 2015-05-28 | Thomas Robert Bain (Director) | Buy | 10,000 | 3.85 | 38,460 |
| 2015-03-10 | Brandom Donald K. (SVP, Product Development) | Option Ex | 50,000 | 1.25 | 62,500 |
| 2014-12-12 | Brandom Donald K. (SVP, Product Development) | Sale | 6,312 | 3.52 | 22,186 |
| 2014-12-11 | Brandom Donald K. (SVP, Product Development) | Sale | 596 | 3.77 | 2,243 |
| 2014-12-09 | Brandom Donald K. (SVP, Product Development) | Sale | 3,000 | 3.83 | 11,481 |
| 2014-12-08 | Brandom Donald K. (SVP, Product Development) | Sale | 91 | 3.98 | 361 |
| 2014-11-21 | Stockman Robert Bernard (Chairman and CEO) | Buy | 25,000 | 3.19 | 79,750 |
| 2014-11-20 | Stockman Robert Bernard (Chairman and CEO) | Buy | 5,550 | 2.75 | 15,262 |
| 2014-10-20 | Anderson Jeffrey A. (SVP, Clinical & Regulatory) | Option Ex | 5,000 | 1.00 | 5,000 |
| 2014-09-18 | Thompson Katrina (CFO & Secretary) | Option Ex | 23,575 | 1.32 | 31,236 |
| 2014-09-10 | Zeltinger Joan K. (VP, Scientific Affairs) | Option Ex | 20,000 | 1.00 | 20,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of RVA listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Reva Medical, Inc. (symbol RVA,
CIK number 1496268) see
the Securities and Exchange Commission (SEC) website.